According to one of my buddies who hangs with the big boys-------------
Word is out on INSM----------The closer we get to data release the higher we`re gonna go.Things can definitely heat up here pretty quick and if all goes well data wise,they could really run this up to 50 or even much higher, fast.I was here for the MMD fiasco so I know things don`t always go your way,but things feel much better this go around.
They don`t have to think about the obvious,meaning as soon as IPLEX is free from any opt ins,(2018)-we`ll have a whole nother promising drug to cheer about.After all the company has stated that they plan to be a stand alone big pharma have`nt they? Well you need more than one drug for that-Enter IPLEX. 4-5 years away from glory